David C. Peck

David C. Peck


David C. Peck, Co-Chair of the firm's Health Care & FDA Practice, works with emerging growth companies, established entities and private equity firms in executing their strategic plans. He assists companies beginning with corporate formation, obtaining and structuring both equity and debt financing, mergers and acquisitions, as well as the integration of acquired operations, undertaking initial public offerings, and continuing through to liquidity and exit strategies.

David understands the unique needs of high growth companies. He has served as the General Counsel and Vice President of Finance of a high growth, public company, as well as being the President of a private, start-up company that raised multiple rounds of equity and debt financing and grew to more than $75 million in revenues in less than two years. David has a wide range of experience including the areas of health care technology and services, life sciences, technology, corporate restructurings, and aviation.


  • Corporate formation and governance
  • Private equity/venture financing and investments
  • Mergers and acquisitions, joint ventures and strategic partnerships
  • Restructurings
Read More +



  • Health care representation has included: OMNI Home Health, a home health care provider; TMS Health, a provider of inbound and outbound marketing programs to pharmaceutical and health care companies; SPi Technologies, medical billing and BPO services; Senior Bridge Family Companies, a private pay, home health care provider; iSirona, a health care software and device company; Info-X, a developer of health care IT products; Home Healthcare Resources, a specialty home infusion provider; and MTI Precision Products Inc., X-Tip Technology and Bio-Tip, all medical device companies.
  • Biotechnology, Life Science and Medical Device representation has included: Adamis Pharmaceuticals Corporation, Electro-Optical Sciences, Inc., Biogen, Inc., DNA Plant Technology Corporation, Crop Genetics International Corporation, and Pharmaceutical Product Development, Inc. as underwriters' counsel.
  • Restructuring representation has included: Outsource International, ParkStone Medical Information Systems, Kellstrom Industries, Petropac Holdings, Sea Specialties and Apple Capitol Group, as company counsel in connection with reorganization issues, Chapter 11 proceedings, debtor-in-possession (DIP) credit facilities, and asset sales pursuant to Section 363; in addition to acting as counsel to private equity firms and other companies in connection with the purchase of assets and/or stock in connection with 363 sales and plans of reorganization.
  • President and Director, OMNA Medical Partners
  • General Counsel and Vice President of Finance, Inphynet Medical Management Inc.


  • Listed, The Best Lawyers in America, Corporate Law; Health Care Law, 2006-2019
    • Selected, "Lawyer of the Year," Health Care Law, Fort Lauderdale, 2019
  • Listed, The Legal 500 United States, Industry Focus - Health Care - Health Insurers, 2018
  • Listed, Super Lawyers magazine, Florida Super Lawyers, 2011-2014 and 2016-2018
  • Team Member, a Law360 "Florida Powerhouse," 2018
  • Listed, LMG Life Sciences, "Life Science Star," 2016-2018
  • Team Member, Corporate Board Member magazine and FTI Consulting Inc., one of "America’s Best Corporate Law Firms," 13th Annual Legal Industry Study, 2013
  • Listed, Florida Trend magazine, "Legal Elite," Corporate Securities Law, 2012
  • Board of Directors, Brookwood Florida East
  • Member, American Bar Association
  • Member, The Florida Bar
  • Member, New York Bar Association


  • J.D., cum laude, Harvard Law School, 1988
  • M.B.A., Michigan State University, 1982
  • B.S., Michigan State University, 1980
  • Florida
  • 米国 ニューヨーク州